<DOC>
	<DOCNO>NCT00907413</DOCNO>
	<brief_summary>This research study phase III double arm , multicenter , randomize control clinical trial compare endoscopic retrograde cholangiopancreatography ( ERCP ) stenting plus photodynamic therapy ( PDT ) versus ERCP stenting alone adult patient unresectable cholangiocarcinoma . The study objective investigate efficacy photodynamic therapy ( PDT ) increase survival time patient unresectable cholangiocarcinoma ass effect PDT cholestasis health-related quality life ( HRQoL ) .</brief_summary>
	<brief_title>Photodynamic Therapy ( PDT ) Trial Palliation Cholangiocarcinoma</brief_title>
	<detailed_description>The study objective investigate efficacy photodynamic therapy ( PDT ) increase survival time patient unresectable cholangiocarcinoma ass effect PDT cholestasis health-related quality life ( HRQoL ) .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<criteria>Patient age 18 year old Patient diagnose nonresectable cholangiocarcinoma , determine CT within 30 day enrollment CT show Bismuth Tumor Stage : IIIa , IIIb , IV ( Bismuth tumor stage I II eligible participate ) Patients must adequate organ marrow function define : Patient 's INR ≤ 2 within 30 day treatment Patient 's platelet &gt; 50,000/cmm within 30 day treatment Patient 's Absolute Neutrophil Count ( ANC ) &gt; 1,500/cmm within 30 day treatment Patient 's creatinine ≤ 3 mg/dL within 30 day treatment Patient ability understand willingness comply study procedure provide write informed consent participate study Patient diagnose cholangiocarcinoma 3 month ago Patient metastatic disease Patient acute porphyria Subjects exhibit neurologic cutaneous symptom undergo urinary deltaaminolevulinic acid porphobilinogen dosage test determine severity . Patient pregnant ( Women child bear age must negative pregnancy test prior registration must agree use adequate contraception study therapy ) Patient concurrent non solid malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>cancer</keyword>
	<keyword>bile duct</keyword>
</DOC>